Close Menu
Home » Apogenix Awarded €3M Grant to Test Brain Cancer Drug Companion Dx

Apogenix Awarded €3M Grant to Test Brain Cancer Drug Companion Dx

Feb 16, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Biopharmaceutical firm Apogenix announced today that it has received a €3 million ($3.4 million) grant from the German Federal Ministry of Education and Research to support its ongoing development of a companion diagnostic for its experimental glioblastoma immunotherapy APG101.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

On to Supercomputing

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

More Than a Century Away

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

From the "Cell's View"

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

PLOS Studies Explore Host Responses to Viral Infection, Febrile Illness Culprits

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Sponsored by
Agilent
Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
24
Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

Sponsored by
Hologic

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul
25
Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

Sponsored by
Roche

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

What's Popular?

In Molecular Diagnostics

  1. Liquid Biopsy Assay From MSKCC Approved by New York State

  2. SpeeDx, GSK Sign Test Supply, Development Deal

  3. At ASM Microbe, Stakeholders Discuss Reimbursement Issues for Multiplex Infectious Disease Tests

    Premium

  4. Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

    Premium

  5. AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.